Seite wählen

The app Mika is a digital product of the telemedical company Fosanis and is intended as a support for people suffering from cancer. As a digital companion, it improves the success of therapy and adherence to therapy while taking a holistic approach.
For this purpose, the Cancer Assistant was developed in cooperation with the Charité in Berlin and the University Hospital in Leipzig. Doctors, oncologists, and psychologists helped to develop the companion, which is the first German medical product to be approved to date, in order to provide support with questions before, during, and after cancer treatment. The developers of the app from Fosanis see the psycho-oncological help for patients and their relatives primarily, however, after the cancer therapy by treating physicians, when there are important questions around the everyday life of those affected.
But the Mika app also provides information on diagnoses and treatment options, is also a nutrition guide, and shows, for example, how relaxation works in a tense life situation such as cancer because 492,000 people contract this insidious disease every year.
Fosanis has also managed to get new investors on board. In another round of financing, the digital health company has raised another million. The pan-European venture capitalist Ananda Impact Ventures, IBB Ventures, and the investment company Evodia are among them. Furthermore, Fosanis receives money from the ProFIT program of Investitionsbank Berlin.
Fosanis‘ next goal is to have the Mika app approved as a so-called „app on prescription“ by the German Federal Institute for Drugs and Medical Devices (BfArM) so that patients can benefit from therapy support a health insurance prescription, which could also reduce cancer mortality. With the money from the investors, Fosanis plans to further distribute and expand the app’s applications as well as studies on its proven effectiveness.

Source: KMA Online